Aging in psoriasis vulgaris: female patients are epigenetically older than healthy controls
Status PubMed-not-MEDLINE Language English Country England, Great Britain Media electronic
Document type Journal Article
Grant support
Q40-09
Charles University, Faculty of Medicine in Hradec Kralove
Q40-10
Charles University, Faculty of Medicine in Hradec Kralove
Q40-11
Charles University, Faculty of Medicine in Hradec Kralove
SVV-260543/2020
Charles University, Faculty of Medicine in Hradec Kralove
PubMed
33658053
PubMed Central
PMC7927262
DOI
10.1186/s12979-021-00220-5
PII: 10.1186/s12979-021-00220-5
Knihovny.cz E-resources
- Keywords
- Aging, Comorbidities, Epigenetic clock, Psoriasis,
- Publication type
- Journal Article MeSH
BACKGROUND: Psoriasis vulgaris is a skin autoimmune disease. Psoriatic patients have significantly lowered life expectancy and suffer from various comorbidities. The main goal of the study was to determine whether psoriatic patients experience accelerated aging. As accelerated aging might be the reason for the higher prevalence of comorbidities at lower chronological ages, we also wanted to investigate the relationship between aging and selected parameters of frequent psoriatic comorbidities - endocan, vascular endothelial growth factor and interleukin-17. Samples were obtained from 28 patients and 42 healthy controls. Epigenetic age measurement was based on the Horvath clock. The levels of endocan, vascular endothelial growth factor and interleukin-17 were analyzed using standardized ELISA methods. RESULTS: The difference between the epigenetic age and the chronological age of each individual subject did not increase with the increasing chronological age of patients. We cannot conclude that psoriasis causes accelerated aging. However, the epigenetic and chronological age difference was significantly higher in female patients than in female controls, and the difference was correlated with endocan (r = 0.867, p = 0.0012) and vascular endothelial growth factor (r = 0.633, p = 0.0365) only in female patients. CONCLUSIONS: The findings suggest a possible presence of pathophysiological processes that occur only in female psoriatic patients. These processes make psoriatic females biologically older and might lead to an increased risk of comorbidity occurrence. This study also supports the idea that autoimmune diseases cause accelerated aging, which should be further explored in the future.
See more in PubMed
Pollock RA, Abji F, Gladman DD. Epigenetics of psoriatic disease: a systematic review and critical appraisal. J Autoimmun. 2017;78:29–38. doi: 10.1016/j.jaut.2016.12.002. PubMed DOI
Beranek M, Fiala Z, Kremlacek J, Andrys C, Krejsek J, Hamakova K, et al. Changes in circulating cell-free DNA and nucleosomes in patients with exacerbated psoriasis. Arch Dermatol Res. 2017;309(10):815–821. doi: 10.1007/s00403-017-1785-5. PubMed DOI
Boehncke WH, Schon MP. Psoriasis. Lancet. 2015;386(9997):983–994. doi: 10.1016/S0140-6736(14)61909-7. PubMed DOI
Schon MP. Adaptive and innate immunity in psoriasis and other inflammatory disorders. Front Immunol. 2019;10:1764. doi: 10.3389/fimmu.2019.01764. PubMed DOI PMC
Egeberg A. Psoriasis and comorbidities. Epidemiological studies. Dan Med J. 2016;63(2):B5201. PMID: 26836804 PubMed
Gelfand JM, Troxel AB, Lewis JD, Kurd SK, Shin DB, Wang X, et al. The risk of mortality in patients with psoriasis: results from a population-based study. Arch Dermatol. 2007;143(12):1493–1499. doi: 10.1001/archderm.143.12.1493. PubMed DOI
Gulliver W. Long-term prognosis in patients with psoriasis. Br J Dermatol. 2008;159(Suppl 2):2–9. doi: 10.1111/j.1365-2133.2008.08779.x. PubMed DOI
Ranna D, Andrys C, Krejsek J, Hamakova K, Kremlacek J, Fiala Z, et al. Elevated levels of circulating biomarkers of cell death (nucleosomes) in the patients with plaque psoriasis treated with the Goeckerman regimen. Bratisl Lek Listy. 2014;115(4):229–232. PubMed
Kondelkova K, Borska L, Andrys C, Krejsek J, Hamakova K, Rendarova S, et al. Selected inflammatory and metabolic markers in psoriatic patients treated with Goeckerman therapy. Mediat Inflamm. 2015;2015:979526. doi: 10.1155/2015/979526. PubMed DOI PMC
Wolk K, Schmid R, Gabrielyan O, Christou D, Rieber K, Rolser M, Jakob I, Wiech F, Griesser M, Wohnhaas C, Kokolakis G, Witte-Händel E, Baum P, Sabat R. Integrated microRNA/mRNA expression profiling of the skin of psoriasis patients. J Dermatol Sci. 2020;97(1):9-20. 10.1016/j.jdermsci.2019.11.003. Epub 2019 Nov 30. PMID: 31843230. PubMed
Kong Y, Trabucco SE, Zhang H. Oxidative stress, mitochondrial dysfunction and the mitochondria theory of aging. Interdiscip Top Gerontol. 2014;39:86–107. doi: 10.1159/000358901. PubMed DOI
Phoenix C, de Grey AD. A model of aging as accumulated damage matches observed mortality patterns and predicts the life-extending effects of prospective interventions. Age (Dordr) 2007;29(4):133–189. doi: 10.1007/s11357-007-9038-8. PubMed DOI PMC
Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013;153(6):1194–1217. doi: 10.1016/j.cell.2013.05.039. PubMed DOI PMC
D'Urso A, Brickner JH. Mechanisms of epigenetic memory. Trends Genet. 2014;30(6):230–236. doi: 10.1016/j.tig.2014.04.004. PubMed DOI PMC
Goel N, Karir P, Garg VK. Role of DNA methylation in human age prediction. Mech Ageing Dev. 2017;166:33–41. doi: 10.1016/j.mad.2017.08.012. PubMed DOI
Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 2013;14(10):R115. doi: 10.1186/gb-2013-14-10-r115. PubMed DOI PMC
Horvath S. Erratum to: DNA methylation age of human tissues and cell types. Genome Biol. 2015;16:96. doi: 10.1186/s13059-015-0649-6. PubMed DOI PMC
Horvath S, Raj K. DNA methylation-based biomarkers and the epigenetic clock theory of ageing. Nat Rev Genet. 2018;19(6):371–384. doi: 10.1038/s41576-018-0004-3. PubMed DOI
Horvath S, Garagnani P, Bacalini MG, Pirazzini C, Salvioli S, Gentilini D, et al. Accelerated epigenetic aging in Down syndrome. Aging Cell. 2015;14(3):491–495. doi: 10.1111/acel.12325. PubMed DOI PMC
Marioni RE, Shah S, McRae AF, Ritchie SJ, Muniz-Terrera G, Harris SE, et al. The epigenetic clock is correlated with physical and cognitive fitness in the Lothian birth cohort 1936. Int J Epidemiol. 2015;44(4):1388–1396. doi: 10.1093/ije/dyu277. PubMed DOI PMC
Shen C, Wen L, Ko R, Gao J, Shen X, Zuo X, et al. DNA methylation age is not affected in psoriatic skin tissue. Clin Epigenetics. 2018;10(1):160. doi: 10.1186/s13148-018-0584-y. PubMed DOI PMC
Hugh JM, Weinberg JM. Update on the pathophysiology of psoriasis. Cutis. 2018;102(5S):6–12. PubMed
Huang LH, Lin PH, Tsai KW, Wang LJ, Huang YH, Kuo HC, et al. The effects of storage temperature and duration of blood samples on DNA and RNA qualities. PLoS One. 2017;12(9):e0184692. doi: 10.1371/journal.pone.0184692. PubMed DOI PMC
He XW, Ke SF, Bao YY, Hong WJ, Shen YG, Li C, et al. Serum levels of endocan and endoglin are associated with large-artery atherosclerotic stroke. Clin Chim Acta. 2018;478:157–161. doi: 10.1016/j.cca.2017.12.040. PubMed DOI
Jaipersad AS, Lip GY, Silverman S, Shantsila E. The role of monocytes in angiogenesis and atherosclerosis. J Am Coll Cardiol. 2014;63(1):1–11. doi: 10.1016/j.jacc.2013.09.019. PubMed DOI
Shi YH, Wang YX, Bingle L, Gong LH, Heng WJ, Li Y, et al. In vitro study of HIF-1 activation and VEGF release by bFGF in the T47D breast cancer cell line under normoxic conditions: involvement of PI-3K/Akt and MEK1/ERK pathways. J Pathol. 2005;205(4):530–536. doi: 10.1002/path.1734. PubMed DOI
Amatya N, Garg AV, Gaffen SL. IL-17 signaling: the yin and the Yang. Trends Immunol. 2017;38(5):310–322. doi: 10.1016/j.it.2017.01.006. PubMed DOI PMC
Celletti FL, Hilfiker PR, Ghafouri P, Dake MD. Effect of human recombinant vascular endothelial growth factor165 on progression of atherosclerotic plaque. J Am Coll Cardiol. 2001;37(8):2126–2130. doi: 10.1016/S0735-1097(01)01301-8. PubMed DOI
Malkic Salihbegovic E, Hadzigrahic N, Cickusic AJ. Psoriasis and metabolic syndrome. Med Arch. 2015;69(2):85–87. doi: 10.5455/medarh.2015.69.85-87. PubMed DOI PMC
Horvath S, Gurven M, Levine ME, Trumble BC, Kaplan H, Allayee H, et al. An epigenetic clock analysis of race/ethnicity, sex, and coronary heart disease. Genome Biol. 2016;17(1):171. doi: 10.1186/s13059-016-1030-0. PubMed DOI PMC
Fransquet PD, Wrigglesworth J, Woods RL, Ernst ME, Ryan J. The epigenetic clock as a predictor of disease and mortality risk: a systematic review and meta-analysis. Clin Epigenetics. 2019;11(1):62. doi: 10.1186/s13148-019-0656-7. PubMed DOI PMC
Vignoli A, Tenori L, Luchinat C, Saccenti E. Age and sex effects on plasma metabolite association networks in healthy subjects. J Proteome Res. 2018;17(1):97–107. doi: 10.1021/acs.jproteome.7b00404. PubMed DOI
Marquez EJ, Chung CH, Marches R, Rossi RJ, Nehar-Belaid D, Eroglu A, et al. Sexual-dimorphism in human immune system aging. Nat Commun. 2020;11(1):751. doi: 10.1038/s41467-020-14396-9. PubMed DOI PMC
Fang X, Wang L, Wu C, Shi H, Zhou Z, Montgomery S, et al. Sex hormones, gonadotropins, and sex hormone-binding globulin in infants fed breast Milk, cow Milk formula, or soy formula. Sci Rep. 2017;7(1):4332. doi: 10.1038/s41598-017-04610-y. PubMed DOI PMC
Younes JA, Lievens E, Hummelen R, van der Westen R, Reid G, Petrova MI. Women and their microbes: the unexpected friendship. Trends Microbiol. 2018;26(1):16–32. doi: 10.1016/j.tim.2017.07.008. PubMed DOI
Moulton VR. Sex hormones in acquired immunity and autoimmune disease. Front Immunol. 2018;9:2279. doi: 10.3389/fimmu.2018.02279. PubMed DOI PMC
Yamagata Y, Asada H, Tamura I, Lee L, Maekawa R, Taniguchi K, et al. DNA methyltransferase expression in the human endometrium: down-regulation by progesterone and estrogen. Hum Reprod. 2009;24(5):1126–1132. doi: 10.1093/humrep/dep015. PubMed DOI
Shiota K. DNA methylation profiles of CpG islands for cellular differentiation and development in mammals. Cytogenet Genome Res. 2004;105(2–4):325–334. doi: 10.1159/000078205. PubMed DOI
Lapidus RG, Nass SJ, Davidson NE. The loss of estrogen and progesterone receptor gene expression in human breast cancer. J Mammary Gland Biol Neoplasia. 1998;3(1):85–94. doi: 10.1023/A:1018778403001. PubMed DOI
Asada H, Yamagata Y, Taketani T, Matsuoka A, Tamura H, Hattori N, et al. Potential link between estrogen receptor-alpha gene hypomethylation and uterine fibroid formation. Mol Hum Reprod. 2008;14(9):539–545. doi: 10.1093/molehr/gan045. PubMed DOI
Merola JF, Li T, Li WQ, Cho E, Qureshi AA. Prevalence of psoriasis phenotypes among men and women in the USA. Clin Exp Dermatol. 2016;41(5):486–489. doi: 10.1111/ced.12805. PubMed DOI PMC
Egeberg A, Skov L, Gislason GH, Thyssen JP, Mallbris L. Incidence and prevalence of psoriasis in Denmark. Acta Derm Venereol. 2017;97(7):808–812. doi: 10.2340/00015555-2672. PubMed DOI
Hooper D. Impact of psoriasis on women. J Drugs Dermatol. 2019;18(9):950. PubMed
Wu S, Cho E, Li W, Grodstein F, Qureshi AA. Hormonal factors and risk of psoriasis in women: a cohort study. Acta Derm Venereol. 2016;96(7):927–931. doi: 10.2340/00015555-2312. PubMed DOI
Garshick MS, Vaidean G, Nikain CA, Chen Y, Smilowitz NR, Berger JS. Sex differences in the prevalence of vascular disease and risk factors in young hospitalized patients with psoriasis. Int J Womens Dermatol. 2019;5(4):251–255. doi: 10.1016/j.ijwd.2019.05.003. PubMed DOI PMC
Balta I, Balta S, Demirkol S, Mikhailidis DP, Celik T, Akhan M, et al. Elevated serum levels of endocan in patients with psoriasis vulgaris: correlations with cardiovascular risk and activity of disease. Br J Dermatol. 2013;169(5):1066–1070. doi: 10.1111/bjd.12525. PubMed DOI
Sabry HH, Sabry JH, Daifalla AEH, Akl EM, Hamed AM, Torky AAA. Serum markers for asymptomatic atherosclerosis in Egyptian psoriatic patients: study controlled by Doppler estimation of carotid intima-media thickness. Vasc Health Risk Manag. 2018;14:145–152. doi: 10.2147/VHRM.S164274. PubMed DOI PMC
Sigurdardottir G, Ekman AK, Verma D, Enerback C. Decreased systemic levels of Endocan-1 and CXCL16 in psoriasis are restored following narrowband UVB treatment. Dermatology. 2018;234(5–6):173–179. doi: 10.1159/000491819. PubMed DOI
Malakouti M, Brown GE, Wang E, Koo J, Levin EC. The role of IL-17 in psoriasis. J Dermatolog Treat. 2015;26(1):41–44. doi: 10.3109/09546634.2013.879093. PubMed DOI
Bingol Z, Kose M, Pihtili A, Akpinar T, Tukek T, Kiyan E. Serum endothelial cell specific molecule-1 (endocan) levels in patients with obstructive sleep apnea. Biomark Med. 2016;10(2):177–184. doi: 10.2217/bmm.15.117. PubMed DOI
Szpera-Goździewicz A, Kosicka K, Goździewicz T, Krzyścin M, Wirstlein P, Siemiątkowska A, Główka FK, Wender-Ożegowska E, Markwitz W, Bręborowicz GH. Serum endocan concentration and its correlation with severity of hypertensive disorders in pregnancy. J Matern Fetal Neonatal Med. 2020;33(14):2313-9. 10.1080/14767058.2018.1548597. Epub 2018 Dec 2. PMID: 30501553. PubMed
Abu El-Asrar AM, Nawaz MI, De Hertogh G, Al-Kharashi AS, Van den Eynde K, Mohammad G, et al. The angiogenic biomarker endocan is upregulated in proliferative diabetic retinopathy and correlates with vascular endothelial growth factor. Curr Eye Res. 2015;40(3):321–331. doi: 10.3109/02713683.2014.921312. PubMed DOI
Zablotna M, Sobjanek M, Nedoszytko B, Lange M, Kozicka D, Glen J, et al. Association of psoriasis with the VEGF gene polymorphism in the northern polish population. J Eur Acad Dermatol Venereol. 2013;27(3):319–323. doi: 10.1111/j.1468-3083.2011.04393.x. PubMed DOI
Sankar L, Arumugam D, Boj S, Pradeep P. Expression of Angiogenic factors in psoriasis vulgaris. J Clin Diagn Res. 2017;11(3):EC23–EEC7. PubMed PMC
Shahidi-Dadras M, Haghighatkhah HR, Abdollahimajd F, Younespour S, Partovi Kia M, Zargari O. Correlation between vascular endothelial growth factor and subclinical atherosclerosis in patients with psoriasis. Int J Dermatol. 2016;55(1):52–59. doi: 10.1111/ijd.12842. PubMed DOI
Jain N, Shahal T, Gabrieli T, Gilat N, Torchinsky D, Michaeli Y, et al. Global modulation in DNA epigenetics during pro-inflammatory macrophage activation. Epigenetics. 2019;14(12):1183–1193. doi: 10.1080/15592294.2019.1638700. PubMed DOI PMC
Kim GE, Seidler E, Kimball AB. The relative impact of psoriasis and obesity on socioeconomic and medical outcomes in psoriasis patients. J Eur Acad Dermatol Venereol. 2014;28(2):216–221. doi: 10.1111/jdv.12089. PubMed DOI
Shreberk-Hassidim R, Galili E, Hassidim A, Ramot Y, Merdler I, Baum S, et al. Epidemiology and comorbidities of psoriasis among Israeli adolescents: a large cross-sectional study. Dermatology. 2019;235(6):488–494. doi: 10.1159/000501032. PubMed DOI
Holmannova D, Borsky P, Borska L, Andrys C, Hamakova K, Rehacek V, et al. Metabolic Syndrome, Clusterin and Elafin in Patients with Psoriasis Vulgaris. Int J Mol Sci. 2020;21(16). PubMed PMC